CLICK HERE TO VIEW THE AGENDA

The U.S. Food and Drug Administration (FDA) will host a workshop on drug development and CFS and ME on April 25-26, 2013. This FDA workshop will also serve as the first of 20 disease-specific meetings where the FDA will gather patients' perspectives as part of a mandated "Patient-Focused Drug Development Initiative."

The CFIDS Association of America believes this is a historic opportunity for the ME/CFS* community to establish ME/CFS as an important priority for drug development. We've launched a special patient-focused survey and six-part spring webinar series to inform, educate and engage with the community so that our individual contributions have amplified impact. Learn more here: http://bit.ly/spring-series